GLITOS 15 pioglitazone (as hydrochloride) 15mg tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

pioglitazone hydrochloride, Quantity: 16.536 mg (Equivalent: pioglitazone, Qty 15 mg)

Disponível em:

Arrotex Pharmaceuticals Pty Ltd

DCI (Denominação Comum Internacional):

Pioglitazone hydrochloride

Forma farmacêutica:

Tablet

Composição:

Excipient Ingredients: carmellose calcium; hyprolose; magnesium stearate; lactose monohydrate

Via de administração:

Oral

Unidades em pacote:

50 tablets, 7 tablets, 28 tablets, 98 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Resumo do produto:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with '140' on one side and '15' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2011-10-26